Leclaza Combination Therapy Study Published in NEJM, Raising Expectations for FDA Approval A study demonstrating the superior efficacy of the combination therapy of Yuhan Corporation's non-small cell lung cancer (NSCLC)… Cheon Okhyeon 2024-06-28